Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
Clinical trial NCT02168491 · COMPLETED
Trial details
- NCT number
- NCT02168491
- Sponsor
- Medical University of Vienna
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.